Cancer Genetics, Inc. Granted Patent for Kidney Cancer Diagnosis & Typing Using a Proprietary Genomic Method
11/6/2013 9:40:51 AM
RUTHERFORD, N.J., Nov. 6, 2013 (GLOBE NEWSWIRE) -- Cancer Genetics, Inc. (Nasdaq:CGIX) ("CGI" or the "Company"), a DNA based diagnostics company focused on developing genomic-based, oncology tests and services, received a formal Notice of Allowance from the United States Patent and Trademark Office (USPTO) for its patent application covering a panel of probes for use in its proprietary methods for the detection and differentiation of kidney cancer.
Help employers find you! Check out all the jobs and post your resume.
comments powered by